Compounds > 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine
Page last updated: 2024-11-13
1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine
Description
**1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine (PGPC)** is a synthetic phospholipid analog. It is a modified version of phosphatidylcholine (PC), a major component of cell membranes.
**Structure:**
* **Palmitoyl (16:0):** A saturated fatty acid chain with 16 carbon atoms.
* **Glutaroyl (5:0):** A saturated fatty acid chain with 5 carbon atoms.
* **Glycerol:** A three-carbon alcohol.
* **Phosphorylcholine:** A phosphate group linked to choline.
**Importance for Research:**
**1. Cell Membrane Research:**
* PGPC can be used as a tool to study the properties and functions of cell membranes.
* It can be incorporated into artificial membranes (liposomes) to create model systems for studying membrane transport, protein interactions, and other processes.
**2. Drug Delivery Systems:**
* PGPC has been investigated as a potential carrier for drug delivery.
* Its unique chemical structure and ability to interact with cell membranes make it suitable for encapsulating and delivering drugs.
**3. Neurological Research:**
* PGPC has shown potential benefits in the treatment of neurological disorders, such as Alzheimer's disease and Parkinson's disease.
* It has been reported to protect neurons from damage and improve cognitive function.
**4. Inflammation and Immunology:**
* PGPC has anti-inflammatory properties.
* It has been shown to inhibit the production of inflammatory mediators and reduce inflammation in animal models.
**5. Anti-cancer Activity:**
* Some studies suggest that PGPC may have anti-cancer activity.
* It has been shown to inhibit the growth of certain cancer cells.
**6. Other Applications:**
* PGPC has also been investigated for its potential use in cosmetics, food additives, and other applications.
**Conclusion:**
PGPC is a versatile phospholipid analog that has numerous applications in research. Its unique structure and biological properties make it a valuable tool for studying cell membranes, developing drug delivery systems, and exploring new therapeutic strategies for various diseases.
2-O-glutaroyl-1-O-palmitoyl-sn-glycero-3-phosphocholine : A 1,2-diacyl-sn-glycero-3-phosphocholine having palmitoyl and glutaroyl groups at positions 1 and 2 respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 46907872 |
CHEBI ID | 61822 |
SCHEMBL ID | 22607951 |
MeSH ID | M0350275 |
Synonyms (24)
Synonym |
pc(16:0/5:0(cooh)) |
LMGP20010006 |
1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine |
1-hexadecanoyl-2-glutaroyl-sn-glycero-3-phosphocholine |
pgpc |
1-palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine |
1-o-palmitoyl-2-o-glutaroyl-sn-glycero-3-phosphocholine |
1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine |
(2r)-2-[(4-carboxybutanoyl)oxy]-3-(palmitoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate |
1-palmitoyl-2-glutaryl-glycerophosphocholine |
1-o-palmitoyl-2-o-glutaryl-sn-glycero-3-phosphocholine |
2-o-glutaryl-1-o-palmitoyl-sn-glycero-3-phosphocholine |
CHEBI:61822 , |
2-o-glutaroyl-1-o-palmitoyl-sn-glycero-3-phosphocholine |
EPITOPE ID:153524 |
DTXSID50677185 |
(2r)-2-[(4-carboxybutanoyl)oxy]-3-(hexadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate |
pgpc, 1-palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine, powder |
pgpc, 1-palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine, chloroform |
Q27131426 |
CDZVJFRXJAUXPP-AREMUKBSSA-N |
1- palmitoyl- 2- glutaryl phosphatidylcholine |
SCHEMBL22607951 |
AKOS040754955 |
Research Excerpts
Toxicity
Dosage Studied
Excerpt | Relevance | Reference |
" We found a dose-response relationship for mGFP-GPI nanoplatform disintegration upon addition of POVPC, correlating with the signal of the apoptosis marker Annexin V-Cy3." | ( Oxidized Phospholipids Inhibit the Formation of Cholesterol-Dependent Plasma Membrane Nanoplatforms. Brameshuber, M; Deigner, HP; Hermetter, A; Manner, C; Peksel, B; Péter, M; Rossboth, BK; Schütz, GJ; Sevcsik, E; Török, Z, 2016) | 0.43 |
Drug Classes (1)
Class | Description |
1,2-diacyl-sn-glycero-3-phosphocholine | The conjugate base of a 1,2-diacyl-sn-glycero-3-phosphocholine compound formed by deprotonation of the phosphate OH group. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (21)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (42.86) | 29.6817 |
2010's | 11 (52.38) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.85
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.85 (24.57) | Research Supply Index | 3.14 (2.92) | Research Growth Index | 4.98 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 1 (4.76%) | 5.53% |
Reviews | 2 (9.52%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 18 (85.71%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |